/Companies

Neoantigenics

Charlottesville, US · Founded 2012 · Delaware corporation · 1 known investors

Find your way into Neoantigenics

Sign up to see every warm intro you have to Neoantigenics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Neoantigenics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

Neoantigenics was founded in 2012 by John C. Herr.

JC
John C. HerrFounder
EJ
Edward J. LearyExecutive
BA
Brian A. PollokExecutive

Board

FE
Fred EshelmanBoard directorPrincipal at Eshelman Ventures, LLC

Investors · 1

Reported raises · per SEC filings

Form D private placements

$3M disclosed across 1 round · 2015

▶$3MraisedFeb 2015 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Edward J. LearyExecutive Officer, Promoter
  • Brian A. PollokExecutive Officer, Director, Promoter
  • John C. HerrExecutive Officer, Director, Promoter
  • Fred EshelmanDirector
Offering amount
$3M
Amount sold
$3M
Proceeds to insiders
$370K
First sale
Feb 2015
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Neoantigenics?
Neoantigenics was founded by John C. Herr in 2012.
Who are Neoantigenics's investors?
Neoantigenics's investors include Eshelman Ventures, LLC.
How much funding has Neoantigenics raised?
Neoantigenics has disclosed $3M raised across 1 round.
Where is Neoantigenics headquartered?
Neoantigenics is headquartered in Charlottesville, US.